{"id":"https://openalex.org/W7224624419","doi":"https://doi.org/10.3390/ph19111710","title":"Physicochemical Stability and Pharmaceutical Compatibility of Ciprofol with Five Adjuvant Drugs for Gastrointestinal Endoscopy: An In Vitro Evaluation","display_name":"Physicochemical Stability and Pharmaceutical Compatibility of Ciprofol with Five Adjuvant Drugs for Gastrointestinal Endoscopy: An In Vitro Evaluation","publication_year":2026,"publication_date":"2026-10-29","ids":{"openalex":"https://openalex.org/W7224624419","doi":"https://doi.org/10.3390/ph19111710"},"language":"en","primary_location":{"id":"doi:10.3390/ph19111710","doi":"https://doi.org/10.3390/ph19111710","is_oa":true,"landing_page_url":"https://doi.org/10.3390/ph19111710","pdf_url":null,"source":{"id":"https://openalex.org/S16322639","display_name":"Pharmaceuticals","issn_l":"1424-8247","issn":["1424-8247"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceuticals","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3390/ph19111710","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101495452","display_name":"Xi Cheng","orcid":"https://orcid.org/0009-0007-2455-9756","observed_orcids":["https://orcid.org/0009-0007-2455-9756"]},"institutions":[{"id":"https://openalex.org/I1285929390","display_name":"Hubei University of Medicine","ror":"https://ror.org/01dr2b756","country_code":"CN","type":"education","lineage":["https://openalex.org/I1285929390"]},{"id":"https://openalex.org/I4210093217","display_name":"China National Pharmaceutical Group Corporation (China)","ror":"https://ror.org/00k3gyk15","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210093217"]},{"id":"https://openalex.org/I4210148938","display_name":"Dongfeng General Hospital","ror":"https://ror.org/04fb6qy86","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210148938"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xi Cheng","raw_affiliation_strings":["School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan 442000, China","Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan 442008, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan 442000, China","institution_ids":["https://openalex.org/I1285929390"]},{"raw_affiliation_string":"Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan 442008, China","institution_ids":["https://openalex.org/I1285929390","https://openalex.org/I4210093217","https://openalex.org/I4210148938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160132080","display_name":"Pengyu Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285929390","display_name":"Hubei University of Medicine","ror":"https://ror.org/01dr2b756","country_code":"CN","type":"education","lineage":["https://openalex.org/I1285929390"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Pengyu Zhang","raw_affiliation_strings":["School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan 442000, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan 442000, China","institution_ids":["https://openalex.org/I1285929390"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160111172","display_name":"Kun Yang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285929390","display_name":"Hubei University of Medicine","ror":"https://ror.org/01dr2b756","country_code":"CN","type":"education","lineage":["https://openalex.org/I1285929390"]},{"id":"https://openalex.org/I4210093217","display_name":"China National Pharmaceutical Group Corporation (China)","ror":"https://ror.org/00k3gyk15","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210093217"]},{"id":"https://openalex.org/I4210148938","display_name":"Dongfeng General Hospital","ror":"https://ror.org/04fb6qy86","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210148938"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Kun Yang","raw_affiliation_strings":["Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan 442008, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan 442008, China","institution_ids":["https://openalex.org/I1285929390","https://openalex.org/I4210093217","https://openalex.org/I4210148938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051074104","display_name":"\u623f\u6d77\u7075","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285929390","display_name":"Hubei University of Medicine","ror":"https://ror.org/01dr2b756","country_code":"CN","type":"education","lineage":["https://openalex.org/I1285929390"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hailing Fang","raw_affiliation_strings":["School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan 442000, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan 442000, China","institution_ids":["https://openalex.org/I1285929390"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047840802","display_name":"Yunjia Ni","orcid":"https://orcid.org/0000-0002-0787-9236","observed_orcids":["https://orcid.org/0000-0002-0787-9236"]},"institutions":[{"id":"https://openalex.org/I1285929390","display_name":"Hubei University of Medicine","ror":"https://ror.org/01dr2b756","country_code":"CN","type":"education","lineage":["https://openalex.org/I1285929390"]},{"id":"https://openalex.org/I4210093217","display_name":"China National Pharmaceutical Group Corporation (China)","ror":"https://ror.org/00k3gyk15","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210093217"]},{"id":"https://openalex.org/I4210148938","display_name":"Dongfeng General Hospital","ror":"https://ror.org/04fb6qy86","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210148938"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yunjia Ni","raw_affiliation_strings":["School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan 442000, China","Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan 442008, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan 442000, China","institution_ids":["https://openalex.org/I1285929390"]},{"raw_affiliation_string":"Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan 442008, China","institution_ids":["https://openalex.org/I1285929390","https://openalex.org/I4210093217","https://openalex.org/I4210148938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160119289","display_name":"Yuxin He","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285929390","display_name":"Hubei University of Medicine","ror":"https://ror.org/01dr2b756","country_code":"CN","type":"education","lineage":["https://openalex.org/I1285929390"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yuxin He","raw_affiliation_strings":["School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan 442000, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan 442000, China","institution_ids":["https://openalex.org/I1285929390"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072707219","display_name":"Shao Xiaofen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285929390","display_name":"Hubei University of Medicine","ror":"https://ror.org/01dr2b756","country_code":"CN","type":"education","lineage":["https://openalex.org/I1285929390"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiaofen Shao","raw_affiliation_strings":["School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan 442000, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan 442000, China","institution_ids":["https://openalex.org/I1285929390"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056603408","display_name":"Baoxia Fang","orcid":"https://orcid.org/0000-0002-9299-8271","observed_orcids":["https://orcid.org/0000-0002-9299-8271"]},"institutions":[{"id":"https://openalex.org/I1285929390","display_name":"Hubei University of Medicine","ror":"https://ror.org/01dr2b756","country_code":"CN","type":"education","lineage":["https://openalex.org/I1285929390"]},{"id":"https://openalex.org/I4210093217","display_name":"China National Pharmaceutical Group Corporation (China)","ror":"https://ror.org/00k3gyk15","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210093217"]},{"id":"https://openalex.org/I4210148938","display_name":"Dongfeng General Hospital","ror":"https://ror.org/04fb6qy86","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210148938"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Baoxia Fang","raw_affiliation_strings":["Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan 442008, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan 442008, China","institution_ids":["https://openalex.org/I1285929390","https://openalex.org/I4210093217","https://openalex.org/I4210148938"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037564673","display_name":"Fuchao Chen","orcid":"https://orcid.org/0000-0001-9738-6744","observed_orcids":["https://orcid.org/0000-0001-9738-6744"]},"institutions":[{"id":"https://openalex.org/I1285929390","display_name":"Hubei University of Medicine","ror":"https://ror.org/01dr2b756","country_code":"CN","type":"education","lineage":["https://openalex.org/I1285929390"]},{"id":"https://openalex.org/I4210093217","display_name":"China National Pharmaceutical Group Corporation (China)","ror":"https://ror.org/00k3gyk15","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210093217"]},{"id":"https://openalex.org/I4210148938","display_name":"Dongfeng General Hospital","ror":"https://ror.org/04fb6qy86","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210148938"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Fuchao Chen","raw_affiliation_strings":["Hubei Clinical Research Center of Hypertension, Shiyan 442000, China","Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan 442008, China"],"raw_orcid":"https://orcid.org/0000-0001-9738-6744","affiliations":[{"raw_affiliation_string":"Hubei Clinical Research Center of Hypertension, Shiyan 442000, China","institution_ids":[]},{"raw_affiliation_string":"Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan 442008, China","institution_ids":["https://openalex.org/I1285929390","https://openalex.org/I4210093217","https://openalex.org/I4210148938"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5037564673","https://openalex.org/A5056603408"],"corresponding_institution_ids":["https://openalex.org/I1285929390","https://openalex.org/I4210093217","https://openalex.org/I4210148938"],"apc_list":{"value":2900,"currency":"CHF","value_usd":3499},"apc_paid":{"value":2900,"currency":"CHF","value_usd":3499},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.894397,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"19","issue":"11","first_page":"1710","last_page":"1710"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10436","display_name":"Anesthesia and Sedative Agents","score":0.423799991607666,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10436","display_name":"Anesthesia and Sedative Agents","score":0.423799991607666,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14189","display_name":"Intravenous Infusion Technology and Safety","score":0.3345000147819519,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.22139999270439148,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ciprofol","display_name":"ciprofol","score":0.9980000257492065},{"id":"https://openalex.org/keywords/drug-compatibility","display_name":"drug compatibility","score":0.4580000042915344},{"id":"https://openalex.org/keywords/drug-stability","display_name":"drug stability","score":0.4830000102519989},{"id":"https://openalex.org/keywords/lidocaine","display_name":"lidocaine","score":0.9940000176429749},{"id":"https://openalex.org/keywords/atropine","display_name":"atropine","score":0.8370000123977661},{"id":"https://openalex.org/keywords/nicardipine","display_name":"nicardipine","score":0.925000011920929},{"id":"https://openalex.org/keywords/norepinephrine","display_name":"norepinephrine","score":1.0},{"id":"https://openalex.org/keywords/gaba-a-receptor-agonists","display_name":"GABA-A receptor agonists","score":0.7089999914169312},{"id":"https://openalex.org/keywords/drug-degradation","display_name":"drug degradation","score":0.5519999861717224},{"id":"https://openalex.org/keywords/droplet-aggregation","display_name":"droplet aggregation","score":0.9459999799728394},{"id":"https://openalex.org/keywords/osmolality","display_name":"osmolality","score":0.6470000147819519},{"id":"https://openalex.org/keywords/zeta-potential","display_name":"zeta potential","score":0.7490000128746033},{"id":"https://openalex.org/keywords/polydispersity-index","display_name":"polydispersity index","score":0.8059999942779541}],"concepts":[{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6546000242233276},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5674999952316284},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5325000286102295},{"id":"https://openalex.org/C86181022","wikidata":"https://www.wikidata.org/wiki/Q196823","display_name":"Zeta potential","level":3,"score":0.4553000032901764},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41350001096725464},{"id":"https://openalex.org/C2778162923","wikidata":"https://www.wikidata.org/wiki/Q4990531","display_name":"Anesthetic","level":2,"score":0.40959998965263367},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.38589999079704285},{"id":"https://openalex.org/C2780149897","wikidata":"https://www.wikidata.org/wiki/Q216935","display_name":"Lidocaine","level":2,"score":0.3587000072002411},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.35690000653266907},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.35019999742507935},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.3368000090122223},{"id":"https://openalex.org/C2780820201","wikidata":"https://www.wikidata.org/wiki/Q173235","display_name":"Analgesic","level":2,"score":0.33480000495910645},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.3336000144481659},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.3212999999523163},{"id":"https://openalex.org/C2775859210","wikidata":"https://www.wikidata.org/wiki/Q26272","display_name":"Atropine","level":2,"score":0.31029999256134033},{"id":"https://openalex.org/C2778043224","wikidata":"https://www.wikidata.org/wiki/Q729213","display_name":"Nicardipine","level":3,"score":0.3046000003814697},{"id":"https://openalex.org/C45904493","wikidata":"https://www.wikidata.org/wiki/Q912807","display_name":"Active ingredient","level":2,"score":0.2924000024795532},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.28380000591278076},{"id":"https://openalex.org/C207673951","wikidata":"https://www.wikidata.org/wiki/Q1303150","display_name":"Compounding","level":2,"score":0.28049999475479126},{"id":"https://openalex.org/C2776525901","wikidata":"https://www.wikidata.org/wiki/Q411325","display_name":"Atenolol","level":3,"score":0.26660001277923584},{"id":"https://openalex.org/C2778994108","wikidata":"https://www.wikidata.org/wiki/Q1868462","display_name":"Local anesthetic","level":2,"score":0.26109999418258667},{"id":"https://openalex.org/C2779253243","wikidata":"https://www.wikidata.org/wiki/Q410412","display_name":"Carbamazepine","level":3,"score":0.2531999945640564},{"id":"https://openalex.org/C2778689640","wikidata":"https://www.wikidata.org/wiki/Q113259","display_name":"Anticholinergic","level":2,"score":0.2513999938964844}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3390/ph19111710","doi":"https://doi.org/10.3390/ph19111710","is_oa":true,"landing_page_url":"https://doi.org/10.3390/ph19111710","pdf_url":null,"source":{"id":"https://openalex.org/S16322639","display_name":"Pharmaceuticals","issn_l":"1424-8247","issn":["1424-8247"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceuticals","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3390/ph19111710","doi":"https://doi.org/10.3390/ph19111710","is_oa":true,"landing_page_url":"https://doi.org/10.3390/ph19111710","pdf_url":null,"source":{"id":"https://openalex.org/S16322639","display_name":"Pharmaceuticals","issn_l":"1424-8247","issn":["1424-8247"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceuticals","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9074000120162964,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W1990488664","https://openalex.org/W2072256476","https://openalex.org/W2087828608","https://openalex.org/W2091685528","https://openalex.org/W2110442238","https://openalex.org/W2120604456","https://openalex.org/W2141246201","https://openalex.org/W2171497914","https://openalex.org/W2856107092","https://openalex.org/W2903936751","https://openalex.org/W3010066194","https://openalex.org/W3133133926","https://openalex.org/W3192169136","https://openalex.org/W3217237844","https://openalex.org/W4309569768","https://openalex.org/W4311076053","https://openalex.org/W4313400113","https://openalex.org/W4316672682","https://openalex.org/W4378516240","https://openalex.org/W4379375549","https://openalex.org/W4385662287","https://openalex.org/W4387504597","https://openalex.org/W4402324492","https://openalex.org/W4403529450","https://openalex.org/W4405960075","https://openalex.org/W4408815546"],"related_works":["https://openalex.org/W4412026065","https://openalex.org/W4417323579","https://openalex.org/W7131231411","https://openalex.org/W4412827253","https://openalex.org/W2114469764","https://openalex.org/W2131385369","https://openalex.org/W7099530502","https://openalex.org/W2526959664","https://openalex.org/W4391362596","https://openalex.org/W2142047486"],"abstract_inverted_index":{"Background/Objectives:":[0],"Ciprofol":[1],"is":[2,32],"a":[3,33,132,153,166],"novel":[4],"GABA\u2090-receptor":[5],"agonist":[6],"sedative":[7],"widely":[8],"used":[9],"for":[10,45,124,251],"gastrointestinal":[11,260],"endoscopic":[12,38,261],"sedation\u2013anesthesia":[13],"due":[14],"to":[15,237],"its":[16],"rapid":[17],"onset,":[18],"fast":[19],"recovery":[20],"and":[21,76,81,99,104,115,157,172,189,215,231,255],"favorable":[22],"cardiovascular":[23],"tolerance.":[24],"Intravenous":[25],"anesthetic":[26],"drug":[27,106],"administration":[28],"via":[29],"Y-site":[30],"co-infusion":[31],"common":[34],"clinical":[35,79],"practice":[36],"during":[37,259],"procedures,":[39],"yet":[40],"systematic":[41],"physicochemical":[42,89,222],"compatibility":[43],"data":[44],"ciprofol":[46,64,211],"with":[47,70,152,212,228],"adjuvant":[48],"injectable":[49],"agents":[50],"remain":[51],"limited.":[52],"Methods:":[53],"In":[54],"this":[55],"in":[56,139,200],"vitro":[57,201],"study":[58],"performed":[59],"under":[60,176],"static":[61,199],"laboratory":[62],"conditions,":[63],"injection":[65],"was":[66],"mixed":[67],"1:1":[68],"(v/v)":[69],"lidocaine,":[71],"nicardipine,":[72],"norepinephrine,":[73],"cisatracurium":[74,128,179,229],"besilate":[75,129,180,230],"atropine":[77],"at":[78,83,110,149,204],"concentrations":[80],"stored":[82],"(25":[84,205],"\u00b1":[85,206],"1)":[86,207],"\u00b0C.":[87],"Multiple":[88],"indicators,":[90],"including":[91],"macroscopic\u2013microscopic":[92],"morphology,":[93],"pH,":[94],"zeta":[95,168],"potential,":[96],"droplet":[97,174,242],"size":[98,147],"polydispersity":[100],"index":[101],"(PDI),":[102],"osmolality,":[103],"residual":[105],"content,":[107],"were":[108,122,143],"evaluated":[109],"0,":[111],"2,":[112],"4,":[113],"6":[114],"8":[116,225],"h.":[117,226],"Results:":[118],"No":[119],"macroscopic":[120],"abnormalities":[121],"observed":[123],"all":[125],"admixtures.":[126],"The":[127,162],"group":[130],"showed":[131],"0.6-unit":[133],"pH":[134,137],"shift,":[135],"whereas":[136],"changes":[138],"the":[140],"other":[141],"groups":[142],"within":[144],"\u00b10.2.":[145],"Droplet":[146],"remained":[148],"200\u2013210":[150],"nm,":[151],"PDI":[154],"<":[155],"0.2,":[156],"osmolality":[158],"varied":[159],"below":[160,182],"5%.":[161],"lidocaine":[163,232],"admixture":[164],"exhibited":[165],"low":[167],"potential":[169],"(~5":[170],"mV)":[171],"obvious":[173,219],"aggregation":[175],"microscopy.":[177],"Chemically,":[178],"degraded":[181],"50%":[183],"of":[184,193,210,221],"baseline,":[185],"while":[186],"atropine,":[187,213],"norepinephrine":[188,216],"nicardipine":[190,214],"maintained":[191],"95\u2013105%":[192],"their":[194],"initial":[195],"concentrations.":[196],"Conclusions:":[197],"Under":[198],"mixing":[202],"conditions":[203],"\u00b0C,":[208],"admixtures":[209],"displayed":[217],"no":[218],"signs":[220],"destabilization":[223],"over":[224],"Co-administration":[227],"should":[233],"be":[234],"avoided":[235],"owing":[236],"severe":[238],"chemical":[239],"degradation":[240],"or":[241],"aggregation.":[243],"These":[244],"experimental":[245],"findings":[246],"provide":[247],"laboratory-derived":[248],"reference":[249],"evidence":[250],"safe":[252],"pharmaceutical":[253],"compounding":[254],"rational":[256],"intravenous":[257],"co-administration":[258],"procedures.":[262]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-30T00:00:00"}
